Immunocore Holdings (IMCR) Debt to Equity: 2022-2025
Historic Debt to Equity for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $0.99.
- Immunocore Holdings' Debt to Equity fell 4.21% to $0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.99, marking a year-over-year decrease of 4.21%. This contributed to the annual value of $1.08 for FY2024, which is 732.77% up from last year.
- Latest data reveals that Immunocore Holdings reported Debt to Equity of $0.99 as of Q3 2025, which was down 1.91% from $1.01 recorded in Q2 2025.
- Immunocore Holdings' 5-year Debt to Equity high stood at $1.22 for Q2 2024, and its period low was $0.13 during Q4 2023.
- In the last 3 years, Immunocore Holdings' Debt to Equity had a median value of $1.03 in 2024 and averaged $0.96.
- In the last 5 years, Immunocore Holdings' Debt to Equity soared by 732.77% in 2024 and then fell by 17.27% in 2025.
- Over the past 4 years, Immunocore Holdings' Debt to Equity (Quarterly) stood at $0.14 in 2022, then declined by 7.73% to $0.13 in 2023, then soared by 732.77% to $1.08 in 2024, then dropped by 4.21% to $0.99 in 2025.
- Its Debt to Equity was $0.99 in Q3 2025, compared to $1.01 in Q2 2025 and $1.03 in Q1 2025.